• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Haematology research in India: past, present and future.印度的血液学研究:过去、现在与未来。
Indian J Hematol Blood Transfus. 2011 Jun;27(2):55-64. doi: 10.1007/s12288-011-0062-6. Epub 2011 May 8.
2
Historical perspective of Indian neurology.印度神经病学的历史视角。
Ann Indian Acad Neurol. 2013 Oct;16(4):467-77. doi: 10.4103/0972-2327.120422.
3
Applications of Next Generation Sequencing in Haematological Disorders-Indian Status: Updates from ISHBT 2018.下一代测序技术在血液系统疾病中的应用——印度现状:ISHBT 2018年最新进展
Indian J Hematol Blood Transfus. 2019 Jan;35(1):17-21. doi: 10.1007/s12288-018-01068-4. Epub 2019 Jan 17.
4
WHO at country level.世界卫生组织在国家层面。
Lancet. 1998 Mar 7;351(9104):743-7. doi: 10.1016/S0140-6736(97)12451-5.
5
Funding opportunities for higher learning, medical and nursing research in India: An overview.印度高等教育、医学及护理研究的资金资助机会:概述
J Family Med Prim Care. 2022 Aug;11(8):4240-4245. doi: 10.4103/jfmpc.jfmpc_2197_21. Epub 2022 Aug 30.
6
Evaluation of research in India - are we doing it right?对印度研究的评估——我们做得对吗?
Indian J Med Ethics. 2018 Jul-Sep;3(3):221-229. doi: 10.20529/IJME.2018.024. Epub 2018 Mar 23.
7
Medical Research in Medical College in India: Current Scenario and Ways to Improve it.印度医学院的医学研究:现状与改进方法
J Assoc Physicians India. 2019 Apr;67(4):71-73.
8
What is wrong with the MCI?轻度认知障碍是怎么回事?
Indian J Med Ethics. 2016 Oct-Dec;1(4):262-263. doi: 10.20529/IJME.2016.076.
9
[Indian workers in Oman].[在阿曼的印度工人]
Tiers Monde (1960). 1985 Jul-Sep;26(103):567-82.
10
Funding opportunities for health research in India - A technical scan.印度卫生研究的资金机会——一项技术扫描。
Indian J Public Health. 2020 Oct-Dec;64(4):421-424. doi: 10.4103/ijph.IJPH_9_20.

引用本文的文献

1
Assessment of Beliefs, Behaviors, and Opinions About Blood Donation in Telangana, India-A Cross Sectional Community-Based Study.印度特伦甘纳邦关于献血的信仰、行为和态度评估-一项基于社区的横断面研究。
Front Public Health. 2021 Dec 9;9:785568. doi: 10.3389/fpubh.2021.785568. eCollection 2021.

本文引用的文献

1
Prevalence and molecular characterization of alpha-thalassemia syndromes among Indians.印度人中α地中海贫血综合征的患病率及分子特征
Genet Test. 2008 Jun;12(2):177-80. doi: 10.1089/gte.2007.0080.
2
Ex vivo expansion of umbilical cord blood stem cells using different combinations of cytokines and stromal cells.使用细胞因子和基质细胞的不同组合对脐带血干细胞进行体外扩增。
Acta Haematol. 2007;118(3):153-9. doi: 10.1159/000108630. Epub 2007 Sep 20.
3
Red cell pyruvate kinase deficiency in neonatal jaundice cases in India.印度新生儿黄疸病例中的红细胞丙酮酸激酶缺乏症
Indian J Pediatr. 2006 Nov;73(11):985-8. doi: 10.1007/BF02758302.
4
Production of murine monoclonal anti-B.鼠源抗B单克隆抗体的制备
Indian J Med Res. 2006 Apr;123(4):561-4.
5
A new factor in the production and cure of macrocytic anaemias and its relation to other haemopoietic principles curative in pernicious anaemia.巨细胞性贫血产生与治愈过程中的一个新因素及其与恶性贫血其他造血治疗原则的关系。
Biochem J. 1937 Nov;31(11):2136-47. doi: 10.1042/bj0312136.
6
Use of a new enzyme-linked immunosorbent assay for the detection of type 2N von Willebrand disease and its prevalence in an Indian population.一种用于检测2N型血管性血友病的新型酶联免疫吸附测定法的应用及其在印度人群中的患病率。
Blood Coagul Fibrinolysis. 2006 Jan;17(1):7-11. doi: 10.1097/01.mbc.0000198048.42634.5a.
7
Surgery for hemophilia in developing countries.发展中国家的血友病手术治疗
Semin Thromb Hemost. 2005 Nov;31(5):538-43. doi: 10.1055/s-2005-922225.
8
Molecular characterization of factor IX gene mutations in 53 patients with haemophilia B in India.印度53例B型血友病患者IX因子基因突变的分子特征分析
Thromb Haemost. 2005 Oct;94(4):883-6.
9
Relatively high frequency of VWD types 3 and 2 in a cohort of Indian patients: the role of multimeric analysis.印度患者队列中血管性血友病3型和2型的相对高发病率:多聚体分析的作用
J Thromb Haemost. 2005 Jun;3(6):1321-2. doi: 10.1111/j.1538-7836.2005.01336.x.
10
Six novel mutations including triple heterozygosity for Phe31Ser, 514delT and 516T-->G factor X gene mutations are responsible for congenital factor X deficiency in patients of Nepali and Indian origin.包括苯丙氨酸31位丝氨酸、514位缺失胸腺嘧啶和516位胸腺嘧啶突变为鸟嘌呤的三重杂合性在内的6种新突变,是尼泊尔和印度裔患者先天性因子X缺乏症的病因。
J Thromb Haemost. 2005 Jul;3(7):1482-7. doi: 10.1111/j.1538-7836.2005.01339.x. Epub 2005 May 9.

印度的血液学研究:过去、现在与未来。

Haematology research in India: past, present and future.

作者信息

Ghosh Kanjaksha

机构信息

National Institute of Immunohaematology, 13th Fl KEM Hospital, Parel, Mumbai, 400012 India.

出版信息

Indian J Hematol Blood Transfus. 2011 Jun;27(2):55-64. doi: 10.1007/s12288-011-0062-6. Epub 2011 May 8.

DOI:10.1007/s12288-011-0062-6
PMID:22654293
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3136671/
Abstract

Haematology research in India is relatively recent in origin. However the pioneers in the field not only did exemplary work when compared to advanced western countries, they also made it a point to develop centres of excellence and human resources for future of haematology work in this country. In this brief overview an effort has been made to give a taste of quality and expanse of haematology research in this country. This review does not claim to have described every bit of haematology research in this country. Our pioneers worked under extremely difficult and trying circumstances on a subject which was limited to funding available from Indian Council of Medical Research. Now the times have changed, several funding agencies in the country are able to provide substantial fund for research. Modern state of the art basic research institutions are tying up with medical colleges for good quality research and the seeds which our pioneers had planted have grown into a mighty tree. It would not be an exaggeration to say we are on the threshold of the golden era of haematology research in this country.

摘要

印度的血液学研究起步相对较晚。然而,该领域的先驱们所做的工作堪称典范,与西方发达国家相比毫不逊色。他们还特别注重为该国血液学工作的未来发展卓越中心和培养人力资源。在这篇简要概述中,我们努力展现该国血液学研究的质量和广度。本综述并不声称涵盖了该国血液学研究的方方面面。我们的先驱们在极其困难和艰苦的条件下开展工作,研究主题仅依赖于印度医学研究理事会提供的资金。如今时代已变,国内几家资助机构能够为研究提供大量资金。现代先进的基础研究机构正与医学院合作开展高质量研究,我们先驱们种下的种子已长成参天大树。毫不夸张地说,我们正处在该国血液学研究黄金时代的开端。